Companies

Vertex Pharmaceuticals

Vertex transformed cystic fibrosis treatment with its CFTR modulator franchise and is expanding into pain, kidney disease, and gene-edited cell therapies. It collaborates with the Cystic Fibrosis Foundation and academic labs on structure-based drug design.

Details

Industry

Biotech

R&D Spend

$3.3B